Who is sponsoring NCT03628183?

NCT03628183 is sponsored by Abbott Nutrition.

What drugs are being tested in NCT03628183?

Interventions in NCT03628183: Hydrolysate Infant Formula 1, Hydrolysate Infant Formula 2.

What condition does NCT03628183 study?

NCT03628183 studies Gastrointestinal Tolerance.

Is NCT03628183 still recruiting?

NCT03628183 is currently completed. Last updated 19 December 2018.

Last reviewed 2018-12-19 · How we verify

NCT03628183

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tolerance of Infants Fed a Hydrolysate Formula

Completed NA Last updated 19 December 2018

What this trial tests

NA trial testing Hydrolysate Infant Formula 1 in Gastrointestinal Tolerance in 51 participants. Completed in 23 November 2018.

Timeline

28 August 2018

Primary endpoint
23 November 2018

23 November 2018

Quick facts

Lead sponsor	Abbott Nutrition
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	51
Start date	28 August 2018
Primary completion	23 November 2018
Estimated completion	23 November 2018
Sites	5 locations across United States

Drugs / interventions tested

Hydrolysate Infant Formula 1
Hydrolysate Infant Formula 2

Conditions studied

Gastrointestinal Tolerance — all drugs for Gastrointestinal Tolerance →

Sponsor

Abbott Nutrition — full company profile →

Who can join

Under 14 Days, any sex, with Gastrointestinal Tolerance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective, randomized, multicenter study to assess the tolerance of infant formulas.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Abbott Nutrition trials

Trials by the same sponsor.

NCT06709001 — An Observational Study to Assess Malnutrition Risk · completed
NCT06368765 — Oral Rehydration Solution and Dehydration Recovery · NA · terminated
NCT06205537 — Muscle Health and Recovery in Older Adults · NA · completed
NCT06130475 — Oral Rehydration Solution in Healthy Adults · NA · completed
NCT06266702 — Evaluation of a Nutritional Technology for Vitamin D Absorption · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03628183 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Abbott Nutrition
Last refreshed: 19 December 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03628183.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing